Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
7
×
boston top stories
deals
7
×
life sciences
national blog main
national top stories
startups
biotech
boston
san francisco blog main
new york blog main
san diego blog main
san francisco top stories
vc
fda
investing
medical devices
new york top stories
san diego top stories
seattle blog main
software
venture capital
clinical trials
healthcare
raleigh-durham blog main
roboticsai
roche
san francisco
accelerator
acetylon pharmaceuticals
airbnb
amazon
amazon web services (aws)
ambys medicines
american well
apple
arrowmark partners
artificial intelligence (a.i.)
athelas
atomwise
What
startup
7
×
big
biotech
deal
developing
device
make
medical
medicines
million
new
patients
therapeutics
acquire
acquisition
adding
admits
ago
aiming
aims
amazon’s
ambys
analytics
approach
atrial
based
beta
biofourmis
bionics
biotechs
blood
boston
business
called
ceo
circulation
classes
closed
combinator
companies
Language
unset
Current search:
startup
×
deals
×
" boston blog main "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion